Skip to main content

Find Clinical Trials

Home
Conditions
Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Refractory

Clinical trial condition

Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Refractory

Explore clinical trials studying Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Refractory. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Refractory trial results

Recruiting

CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma

NCT06209619

Conditions: B-Cell Non-Hodgkin Lymphoma-Recurrent, B-Cell Non-Hodgkin Lymphoma-Refractory, Diffuse Large B-Cell Lymphoma-Recurrent, +9 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details